Aug 8
|
Moody's bank downgrades, Novavax, Hims & Hers, Olaplex: Trending stocks
|
Aug 8
|
Novavax (NVAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
|
Aug 8
|
Novavax (NVAX) Q2 Earnings and Revenues Top Estimates
|
Aug 8
|
UPDATE 2-Novavax posts quarterly profit on COVID vaccine sales
|
Aug 8
|
Novavax Reports Second Quarter 2023 Financial Results and Operational Highlights
|
Aug 8
|
Novavax posts quarterly profit on COVID vaccine sales
|
Aug 8
|
Novavax shares rise after vaccine maker posts surprise profit
|
Aug 7
|
Drug, Biotech Stocks' Q2 Earnings on Aug 8: LLY, LGND & More
|
Jun 23
|
Moderna (MRNA) Seeks FDA Nod for Updated COVID-19 Vaccine
|
Jun 22
|
Billionaire Investor Who Returned 51% in 2022 is Selling These 12 Stocks in 2023
|
Jun 22
|
Biotech ETFs in Focus on Covid Vaccines' Fall Rollout
|
Jun 20
|
What Do Bears Know About Novavax That Bulls Don't?
|
Jun 16
|
US FDA advises COVID vaccine makers to develop shots aimed at XBB.1.5 variant
|
Jun 16
|
FDA Panel Endorses Updating COVID Jab to Target XBB Strain
|
Jun 16
|
Pfizer, Moderna, and Novavax Gear Up for XBB.1.5 Strain Targeted Vaccines as FDA AdCom Unanimously Support
|
Jun 16
|
Exit Strategy: Get Out of These 3 Poor-Performing Stocks Now
|
Mar 18
|
1 Green Flag and 1 Red Flag for Novavax
|
Mar 16
|
Novavax (NVAX) Gains But Lags Market: What You Should Know
|
Mar 16
|
Is Novavax Stock A Sell After Expressing 'Substantial Doubt' About Its Future?
|
Mar 16
|
2 Growth Stocks That Are Trading at a Huge Discount Right Now -- Maybe Rightfully So
|